Shopping Cart
Remove All
Your shopping cart is currently empty
Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate, combines a Thalidomide-based cereblon ligand with a two-unit PEG linker for use in PROTAC technology[1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $84 | 5 days | 5 days | |
| 5 mg | $137 | 5 days | 5 days | |
| 10 mg | $196 | 5 days | 5 days |
| Description | Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate, combines a Thalidomide-based cereblon ligand with a two-unit PEG linker for use in PROTAC technology[1]. |
| In vitro | PROTACs consist of two distinct ligands connected by a linker: one ligand targets an E3 ubiquitin ligase, while the other targets a specific protein. They utilize the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
| Synonyms | Thalidomide-NH-PEG2-C2-NH2 hydrochloride |
| Molecular Weight | 440.88 |
| Formula | C19H25ClN4O6 |
| Cas No. | 2245697-87-2 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.